Jabbour, J. E., Milton, D. R., Gulbis, A. M., Wang, B., Haddad, F. G., Ledesma, C., … Khouri, I. F. (2024). Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma. In Blood (Vol. 144, pp. 7250–7250). American Society of Hematology. https://doi.org/10.1182/blood-2024-203392

Jabbour, Joseph E., Denái R. Milton, Alison M. Gulbis, Bofei Wang, Fadi G. Haddad, Celina Ledesma, Richard E. Champlin, Padmanee Sharma, Ken H. Young, and Issa F. Khouri. “Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma.” In Blood, 144:7250–7250. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-203392.

Jabbour JE, Milton DR, Gulbis AM, Wang B, Haddad FG, Ledesma C, et al. Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma. In: Blood. American Society of Hematology; 2024. p. 7250–7250.

Jabbour, Joseph E., et al. “Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 7250–7250. Crossref, doi:10.1182/blood-2024-203392.

Jabbour JE, Milton DR, Gulbis AM, Wang B, Haddad FG, Ledesma C, Champlin RE, Sharma P, Young KH, Khouri IF. Ten-Year Results of a Phase II Clinical Trial Evaluating Ipilimumab Plus Lenalidomide Combination after Autologous Hematopoietic Cell Transplantation in Patients with Lymphoma. Blood. American Society of Hematology; 2024. p. 7250–7250.